Literature DB >> 9187923

Gastrointestinal pathology in HIV-infected patients.

F Clayton1, C H Clayton.   

Abstract

Specific pathologic processes, particularly oral, esophageal, and intestinal infections, are common in the alimentary tract of AIDS patients. Many of these diseases are adequately assessed only by biopsy with histologic examination. Most are rare or unreported in immunocompetent hosts and are easily missed by those not familiar with them. This article describes the gross or endoscopic and histologic appearances and the diagnostic criteria for enteric pathologic processes seen in HIV-infected individuals.

Entities:  

Mesh:

Year:  1997        PMID: 9187923     DOI: 10.1016/s0889-8553(05)70293-4

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  4 in total

1.  Epithelial Inclusions in Gallbladder Specimens Mimic Parasite Infection: Histologic and Molecular Examination of Reported Cystoisospora belli Infection in Gallbladders of Immunocompetent Patients.

Authors:  Eric A Swanson; Jordon K March; Frederic Clayton; Marc R Couturier; Ramir Arcega; Richard Smith; Kimberley J Evason
Journal:  Am J Surg Pathol       Date:  2018-10       Impact factor: 6.394

2.  Human immunodeficiency virus-associated gastrointestinal disease: common endoscopic biopsy diagnoses.

Authors:  Feriyl Bhaijee; Charu Subramony; Shou-Jiang Tang; Dominique J Pepper
Journal:  Patholog Res Int       Date:  2011-04-26

3.  A rare case of intussusception leading to the diagnosis of acquired immune deficiency syndrome: a case report.

Authors:  Ioannis Kehagias; Stavros N Karamanakos; Spyros Panagiotopoulos; Sofia Giali; Charalambos A Gogos; Fotis Kalfarentzos
Journal:  J Med Case Rep       Date:  2009-02-11

4.  Reconciling Longitudinal Naive T-Cell and TREC Dynamics during HIV-1 Infection.

Authors:  Julia Drylewicz; Nienke Vrisekoop; Tendai Mugwagwa; Anne Bregje de Boer; Sigrid A Otto; Mette D Hazenberg; Kiki Tesselaar; Rob J de Boer; José A M Borghans
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.